GetPortalImpactFactorByIdResp(projectId=1, id=e00423568, cover=https://img.medsci.cn/20260303/1772529334819_8578774.jpg, fullname=Therapeutic Advances in Ophthalmology, abbr=oed, pyear=2018, frequence=Yearly, articleNumbers=186, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量2.94% (2022年为2.22%), issn=2515-8414, greenSci=https://www.greensci.net/search?kw=2515-8414, scijournal=https://www.scijournal.org/impact-factor-of-oed.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.332, medsciHotlight=0.255, medsciHotlight5year=0.052, citescore=4.5, hIndex=null, impactFactor=2.3, orgnization=Sage, orgnizationUrl=https://www.sagepub.com?utm_source=wechat&utm_medium=china_social&utm_campaign=Medsci_oed_260106&utm_content=journalforum, country=USA, countryCn=美国, isOa=1, isOaString=是, sciScie=DOAJ,EBSCO,ProQuest,PMC,Scopus,ESCI, bigclassCas=null, smallclassCas=, website=https://uk.sagepub.com/en-gb/chi/therapeutic-advances-in-ophthalmology/journal203519?utm_source=wechat&utm_medium=china_social&utm_campaign=Medsci_oed_260106&utm_content=journalforum, websiteHits=1054, guideForAuthor=https://www.sagepub.com/docs/default-source/msg/submission-guidelines_-therapeutic-advances-in-ophthalmology_-sage-journals.pdf?utm_source=wechat&utm_medium=china_social&utm_campaign=Medsci_oed_260106&utm_content=journalforum, guideForAuthorHits=976, submitWebsite=https://mc.manuscriptcentral.com/taop?utm_source=wechat&utm_medium=china_social&utm_campaign=Medsci_oed_260106&utm_content=journalforum, submitWebsiteHits=328, content=<p>Therapeutic Advances in Ophthalmology (TAOP) is a peer-reviewed open access journal delivering the highest quality articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of ophthalmology</p>, totalCites=466, brief=oed杂志暂不明确行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=眼科" >眼科</a></strong>”子行业的优秀级杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=oed杂志级别还可以，但是相对来说，比较冷门，关注人数偏少，有些可能是国内不太熟悉，但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿，稿源可能未必丰富，发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=e00423568'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2023, citescore=4.5)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=0.453), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=0.524), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.361), GetImpactFactorMedsciIndexListResponse(year=2025, medsciHotlight=1.094), GetImpactFactorMedsciIndexListResponse(year=2026, medsciHotlight=1.332)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2515-8414[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Therapeutic Advances in Ophthalmology[ta], article_number=45, article_number_cn=1, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)